Showing results (731-740 of 1,529) with videos related to
Sort By:
Pageof 153
The Journal of Clinical Endocrinology and Metabolism|March 26, 2009
Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrationsHelena Forsblad-d'Elia, Hans Carlsten, Fernand Labrie, et al.Journal of Gambling Studies|December 24, 2005
Men & women playing games: gender and the gambling preferences of Iowa gambling treatment program participantsDebi A LaPlante, Sarah E Nelson, Richard A LaBrie, et al.The Prostate|January 1, 1988
Plasma levels of hydroxy-flutamide in patients with prostatic cancer receiving the combined hormonal therapy: an LHRH agonist and flutamideA Bélanger, M Giasson, J Couture, et al.The American Journal of Psychiatry|February 2, 2002
Minor physical anomalies and schizophrenia spectrum disorders: a prospective investigationJason Schiffman, Morten Ekstrom, Joseph LaBrie, et al.Pediatrics|November 29, 2002
Incidence of cranial asymmetry in healthy newbornsWiebke K Peitsch, Constance H Keefer, Richard A LaBrie, et al.Addictive Behaviors|January 31, 2012
Global sleep quality as a moderator of alcohol consumption and consequences in college studentsShannon R Kenney, Joseph W LaBrie, Justin F Hummer, et al.Clinical Genetics|July 4, 2006
A novel mutation in the EIF2AK3 gene with variable expressivity in two patients with Wolcott-Rallison syndromeF Durocher, R Faure, Y Labrie, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 1994
Plasma 3 beta-hydroxy-delta 5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyJ Young, B Couzinet, M Pholsena, et al.Breast Cancer Research and Treatment|January 1, 1993
Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the ratF Labrie, S Li, A Bélanger, et al.Journal De Pharmacologie|January 1, 1983
[New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist]F Labrie, A Dupont, A Belanger, et al.Pageof 153